Skip to main content
Clinical Trials/JPRN-UMIN000027017
JPRN-UMIN000027017
Recruiting
Phase 3

on-randimized confirmatory trial of postoperative concurrent chemoradiotherapy (CCRT) using IMRT for patients with high-risk uterine cervical cancer (JCOG1402, PopCC IMRT-CCRT) - Non-randimized confirmatory trial of postoperative concurrent chemoradiotherapy (CCRT) using IMRT for patients with high-risk uterine cervical cancer (JCOG1402, PopCC IMRT-CCRT)

Japan Clinical Oncology Group (JCOG)0 sites220 target enrollmentApril 17, 2017

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Postoperative uterine cervical cancer patients with high-risk prognostic factors
Sponsor
Japan Clinical Oncology Group (JCOG)
Enrollment
220
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 17, 2017
End Date
October 17, 2026
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Japan Clinical Oncology Group (JCOG)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Simultaneous or metachronous (within 5 years) double cancers except carcinoma in situ or intramucosal tumor. 2\) Active systemic infections to be treated. 3\) Body temperature of 38 or more degrees Celsius 4\) Women during pregnancy or possible pregnancy, within 28 days after delivery, or during breast\-feeding 5\) Severe psychiatric disease 6\) Continuous systemic steroid treatment 7\) Insulin\-dependent or uncontrolled diabetes mellitus 8\) Uncontrolled hypertension 9\) Unstable angina, or history of myocardial infarction within 6 months 10\) HBs antigen or HCV antibody positive 11\) HIV antibody positive 12\) Interstitial pneumonitis, lung fibrosis or severe emphysema on chest CT

Outcomes

Primary Outcomes

Not specified

Similar Trials